Cost-effectiveness analysis has to consider all available evidence when informing inputs by Fabián P. Alvarez, Audrey Petitjean, Joshua Nealon, Rosalind Hollingsworth, Juan Luis López-Belmonte

Connect to this object online.

Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model by Pascal Crépey, Louis Boiron, Rafael Rodrigo Araujo, Juan Guillermo Lopez, Audrey Petitjean, Expedito José de Albuquerque Luna

Connect to this object online.

Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives by Thierry Rigoine de Fougerolles, Théophile Baïssas, Guillaume Perquier, Olivier Vitoux, Pascal Crépey, José Bartelt-Hofer, Hélène Bricout, Audrey Petitjean

Connect to this object online.

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay by Antonio Arbo, Celia Martinez-Cuellar, Cynthia Vazquez, Lucile Bellier, Cecilia Adorno, Hugo Dibarboure, Juan Guillermo Lopez, Audrey Petitjean, Pablo Bianculli

Connect to this object online.

Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis by Pablo Manuel Bianculli, Lucile Bellier, Ignacio Olivera Mangado, Carlos Grau Pérez, Gustavo Mieres, Luis Lazarov, Audrey Petitjean, Hugo Dibarboure, Juan Guillermo Lopez

Connect to this object online.